BRIEF-Spectral expects to release primary end point results for pivotal Euphrates after end of Q3

Fri Aug 19, 2016 8:25am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 19 (Reuters) - Spectral Medical Inc

* Spectral unaware of any material change

* Expects to release primary end point results for pivotal Euphrates trial immediately after end of Q3 ended September 30, 2016

* Confirms it is unaware of any material, undisclosed corporate developments that would account for recent decrease in its share price Source text for Eikon: Further company coverage: